Daily as of 3 Nov 16:00 ET
- Price
- above both $351.87 vs 50 $303.84 / 200 $223.02
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 6 Jul 2026 · projected 26 bars out
CRL | Charles River Laboratories InternationalNYSEHealthcareCommon stock golden cross and death cross projections, cross tests and history
$351.87
+$13.33 (+3.94%)
Charles River Laboratories International (CRL) is a NYSE-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
The 50 SMA has sat above the 200 on the daily since Jul 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $359.41 vs 50 $217.24 / 200 $200.36
- Projection
- No cross projected
- Test
- Cross test window open, no test bar yet
- Last cross
- 🟨Golden cross week of 7 Sep 2026 · projected 19 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $353.12 vs 50 $321.03 / 200 $269.22
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 18 Jun 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| week of 7 Sep 2026 | 🟨Golden moderate | weekly | 19 bars out | Active Cross Test |
| 6 Jul 2026 | 🟨Golden moderate | daily | 26 bars out | Not tested |
| 18 Jun 2026 | 🟨Golden | 4-hour | 26 bars out | Not tested |
| 8 Apr 2026 | 💀Death steep | daily | 28 bars out | 4 bar cross test |
| 26 Feb 2026 | 💀Death | 4-hour | 25 bars out | 1 bar cross test |
About CRL
ExchangeNYSE
InstrumentCommon stock
Median $ volume, 60 d$268M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandlarge